1. Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy. Issue 1 (January 2019) Authors: Cohan, Stanley L; Edwards, Keith; Lucas, Lindsay; Gervasi-Follmar, Tiffany; O'Connor, Judy; Siuta, Jessica; Kamath, Vineetha; Garten, Lore; Chen, Chiayi; Thomas, James; Smoot, Kyle; Kresa-Reahl, Kiren; Spinelli, Kateri J Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 5:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗